“Matt’s deep understanding of the healthcare industry and investment acumen will be instrumental as we mature our operations and move to the next level of our company’s growth,” said Evers. Previously Borowiecki held positions of increasing responsibility at leading investment banks Morgan Stanley, Lehman Brothers and UBS. His healthcare industry experience dates to 2011 when he joined Aetna as its Director of Corporate Development and Enterprise Strategic Planning. In that position, he led Biofourmis’ financial operations as it scaled revenue, customers and employees and surpassed unicorn status.īefore that, Borowiecki was the Head of Capital Transactions and Structuring at MassMutual Financial Group. Before joining Woebot Health, Borowiecki was the Chief Financial Officer at Biofourmis, a technology-enabled care delivery and digital therapeutics company. He reports to Chief Executive Officer Michael Evers.īorowiecki has more than 20 years of global experience in finance, strategy and corporate development across healthcare, insurance and financial services, and has managed acquisitions, divestitures, joint ventures and debt and equity financings totaling more than $60 billion of value. A member of the senior management team, Borowiecki will lead the company’s financial operations and strategy, including management and financial reporting, budgeting and long-term financial planning, and will also manage its capital structure. SAN FRANCISCO-( BUSINESS WIRE)- Woebot Health today announced that it has appointed Matt Borowiecki as its Chief Financial Officer.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |